Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower
More News related to ATHN
- athenahealth to Present at the 21st Annual Piper Jaffray Health Care Conference
- athenahealth to Host Second Annual Investor Summit
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Athenahealth (ATHN) Issued U.S. Patent for anthenaNet Rules Engine
- U.S. Patent and Trademark Office Grants athenahealth, Inc., a Patent for its Practice Management and Billing Automation System
More News related to CSX
- CSX (CSX) Names David Brown to EVP and COO; Sanborn Promoted to VP and Cheif Transportation Officer
- CSX Transportation Names David Brown Executive Vice President and Chief Operating Officer
- National Gateway Creates Long-Term Environmental Benefits
- CSX Corporation Chief Executive Officer to Participate in Wolfe Research Transport Regulatory Conference Panel
- New DOT Fuel Efficiency Study Cites Double-Stack Rail Benefits
More News related to HIG
- The Hartford, Hartford Stage and The Mark Twain House & Museum Kick Off Year-Long Partnership with the Return of Hal Holbrook as Mark Twain
- New Disability Rider On Life Insurance Policies Can Help Protect Small Business Owners From Financial Hardship
- The Hartford Names Christopher Magee Managing Director Of International Financial Products Division
- It's Time To Change The Older Driver Conversation: New Research from MIT AgeLab And The Hartford Helps Drivers Keep The Keys As They Age
- The Hartford Recognized As A Top Military-Friendly Employer
More News related to Special Reports
- Dyax (DYAX) Receives FDA Approval of KALBITOR(R) for Treatment of Acute Attacks of Hereditary Angioedema
- Santarus (SNTS) Earns $20 Million Milestone on FDA Approval for NDA of ZEGERID
- Santarus (SNTS) Jumps Ahead of Expected News
- Hemispherx Biopharma (HEB) Receives Letter for Ampligen From US FDA; FDA Cannot Approve Application in Present Form
- Hemispherx (HEB) Falls 30% as FDA Recommends Another Ampligen Study, Says Can't Approve Application in Present Form
UPGRADES:
Morgan Stanley upgrades U.S. Steel (NYSE: X) from Equal-weight to Overweight.
Goldman Sachs upgrades CSX Corp. (NYSE: CSX) from Neutral to Buy and raises their price target from $36 to $40.
Morgan Stanley upgrades Omniture (Nasdaq: OMTR) from Equalweight to Overweight. Click here to see full color on the upgrade.
JMP Securities upgrades Marvell Technology (Nasdaq: MRVL) from Underperform to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citigroup downgrades Hartford Financial (NYSE: HIG) from Buy to Hold and lowers their price target from $21 to $19, citing a management vacuum after Chairman/CEO Ayer announced plans to retire.
Wachovia downgrades Valeant Pharmaceuticals (NYSE: VRX) to Underperform. Valuation Range: $15 to $17. Click here for the full report.
UBS downgrades Masco (NYSE: MAS) from Neutral to Sell.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Sanford C. Bernstein initiates coverage on State Street (NYSE: STT) with an Outperform rating.
Brean Murray Initiates Coverage on athenahealth (Nasdaq: ATHN) with a Buy. Click here for more color on the coverage.
J.P. Morgan initiates coverage on CarMax (NYSE: KMX) with a Neutral rating. Price target $15.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.99
-0.33Related Entities
- Brean Murray Carret & Co.
- UBS
- JPMorgan
- Goldman Sachs
- Citi
- Morgan Stanley
- Wachovia
- Sanford C. Bernstein
- JMP Securities
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
